At 8.0% CAGR, the South & Central America Deep Brain Simulation Market is Projected to be worth US$ 50.95 million by 2030, says Business Market Insights

According to Business Market Insights research, the South & Central America deep brain simulation market was valued at US$ 27.53 million in 2022 and is expected to reach US$ 50.95 million by 2030, registering a CAGR of 8.0% from 2022 to 2030. Growing research and development activities and increasing demand for minimally invasive surgery are among the critical factors attributed to the South & Central America deep brain simulation market expansion.               

Advances in atlases, imaging techniques, and connectomics improve DBS targeting strategies. Improvements in lead design can make it possible to use segmented contacts for directional stimulation, and improvements in implantable pulse generator (IPG) design can result in small, longer-lasting magnetic resonance imaging (MRI) compatible batteries. Software advances can enable various programming strategies to improve efficacy while minimizing stimulation-related side effects and maximizing battery life. Brain recognition will help clinicians and researchers understand the physiological aspects of DBS and potentially act as another programming strategy. Closed-loop DBS can help tailor stimulation parameters to individual symptoms. In addition, remote and virtual programming could become more viable and accessible. DBS technology is widely used to treat various diseases and symptoms, and research is ongoing to improve current designs. Major market players are focused on introducing updated versions of their already approved DBS devices. On May 24, 2022, Great Lakes NeuroTechnologies (GLNT), a diagnostic and therapeutic system provider, announced that it had initiated a multi-center research study to collect data to improve its Kinesia motor assessment technology, specifically to determine when a patient of Parkinson's disease (PD) is ready to consider advanced therapy such as deep brain stimulation (DBS) or an implantable drug pump and to identify when a patient needs therapy adjustment. The therapy is recommended when oral medications no longer relieve motor symptoms, including stiffness, slow movements, falls and dizziness, freezing, muscle spasms, and dystonia. Therefore, rising research and development activities in the field of deep brain stimulation are expected to bolster the South & Central America deep brain stimulation market growth in the future.  

On the contrary, side effects associated with deep brain stimulation hurdles the growth of South & Central America deep brain simulation market.

Based on product, the South & Central America deep brain simulation market is segmented into single channel deep brain stimulator, dual channel deep brain stimulator, and software and accessories. The dual channel deep brain stimulator segment held 50.0% share of South & Central America deep brain simulation market in 2022, amassing US$ 13.77 million. It is projected to garner US$ 27.49 million by 2030 to expand at 9.0% CAGR during 2022–2030.

Based on application, the South & Central America deep brain simulation market is segmented into Parkinson's disease, tremor, dystonia, epilepsy, Alzheimer's disease, and others. The Parkinson's disease segment held 67.5% share of South & Central America deep brain simulation market in 2022, amassing US$ 20.47 million. It is projected to garner US$ 38.12 million by 2030 to expand at 8.1% CAGR during 2022–2030.

Based on end user, the South & Central America deep brain simulation market is segmented into hospitals, neurology clinics, ambulatory surgical centers, and others. The hospitals segment held 56.0% share of South & Central America deep brain simulation market in 2022, amassing US$ 15.41 million. It is projected to garner US$ 29.89 million by 2030 to expand at 8.6% CAGR during 2022–2030.  

Based on country, the South & Central America deep brain simulation market is segmented into Brazil, Argentina, and the Rest of South & Central America. Our regional analysis states that Brazil captured 59.5% share of South & Central America deep brain simulation market in 2022. It was assessed at US$ 16.37 million in 2022 and is likely to hit US$ 30.84 million by 2030, exhibiting a CAGR of 8.2% during 2022–2030.  

Key players operating in the South & Central America deep brain simulation market are Abbott, Medtronic, Boston Sci, and Leva Nova, among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com